High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer. Issue 5 (May 2015)
- Record Type:
- Journal Article
- Title:
- High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer. Issue 5 (May 2015)
- Main Title:
- High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer
- Authors:
- Sinha, Parul
Kallogjeri, Dorina
Gay, Hiram
Thorstad, Wade L.
Lewis, James S.
Chernock, Rebecca
Nussenbaum, Brian
Haughey, Bruce H. - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="ab010"> <title id="st095">Summary</title> <sec> <title id="st100">Background</title> <p id="sp0010">Due to unique biology and prognosis, precise identification of predictive parameters is critical for p16+ oropharyngeal squamous cell carcinoma (OPSCC). Prior studies showing absence of prognostication from extracapsular spread (ECS) and/or high N-classification in surgically-treated p16+ OPSCC necessitate new, evidence-based prognosticators.</p> </sec> <sec> <title id="st105">Methods</title> <p id="sp0015">A prospectively assembled cohort of 220, transoral surgery + neck dissection ± adjuvant therapy-treated, p16+ OPSCC patients was analyzed. Disease recurrence and disease-specific survival (DSS) were primary endpoints.</p> </sec> <sec> <title id="st110">Results</title> <p id="sp0020">Median follow-up was 59 (12–189) months. Distribution of metastatic node numbers was: 0 in 9.5% (<italic>n</italic> = 21), 1 in 33.6% (<italic>n</italic> = 74), 2 in 17% (<italic>n</italic> = 38), 3 in 14.5% (<italic>n</italic> = 32), 4 in 8.2% (<italic>n</italic> = 18), and <inline-formula><alternatives><inline-graphic xlink:href="ark:/27927/pgjcwgwk9k" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /><mml:math altimg="si1.gif" overflow="scroll" id="d13e1502" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mo>⩾</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>5 in 17% (<italic>n</italic> = 37). ECS was<abstract xml:lang="en" abstract-type="author" id="ab010"> <title id="st095">Summary</title> <sec> <title id="st100">Background</title> <p id="sp0010">Due to unique biology and prognosis, precise identification of predictive parameters is critical for p16+ oropharyngeal squamous cell carcinoma (OPSCC). Prior studies showing absence of prognostication from extracapsular spread (ECS) and/or high N-classification in surgically-treated p16+ OPSCC necessitate new, evidence-based prognosticators.</p> </sec> <sec> <title id="st105">Methods</title> <p id="sp0015">A prospectively assembled cohort of 220, transoral surgery + neck dissection ± adjuvant therapy-treated, p16+ OPSCC patients was analyzed. Disease recurrence and disease-specific survival (DSS) were primary endpoints.</p> </sec> <sec> <title id="st110">Results</title> <p id="sp0020">Median follow-up was 59 (12–189) months. Distribution of metastatic node numbers was: 0 in 9.5% (<italic>n</italic> = 21), 1 in 33.6% (<italic>n</italic> = 74), 2 in 17% (<italic>n</italic> = 38), 3 in 14.5% (<italic>n</italic> = 32), 4 in 8.2% (<italic>n</italic> = 18), and <inline-formula><alternatives><inline-graphic xlink:href="ark:/27927/pgjcwgwk9k" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /><mml:math altimg="si1.gif" overflow="scroll" id="d13e1502" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mo>⩾</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>5 in 17% (<italic>n</italic> = 37). ECS was recorded in 80% (<italic>n</italic> = 159), and N2c–N3 in 17% (<italic>n</italic> = 38). Adjuvant radiotherapy and chemoradiotherapy was administered in 44% and 34%. Recurrence developed in 22 patients (10%); 4 local, 5 regional, 2 regional and distant, and 11 distant. The 3- and 5-year DSS estimates were 94.6% and 93%. Multivariable logistic regression identified <inline-formula><alternatives><inline-graphic xlink:href="ark:/27927/pgjcwgwrbh" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /><mml:math altimg="si2.gif" overflow="scroll" id="d13e1526" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mo>⩾</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>5 nodes and T3–T4 classification as predictors for recurrence. In multivariable Cox analyses, <inline-formula><alternatives><inline-graphic xlink:href="ark:/27927/pgjcwgwr5x" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /><mml:math altimg="si3.gif" overflow="scroll" id="d13e1532" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mo>⩾</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>5 nodes, T3–T4 classification and margins were prognostic for DSS. ECS, N2c–N3 classification and smoking were not prognostic.</p> </sec> <sec> <title id="st115">Conclusions</title> <p id="sp0025">Metastatic node number, not ECS or high N-classification is an independent nodal predictor of outcomes in surgically-treated p16+ OPSCC patients. Despite high DSS (~80%), closer surveillance for recurrence is recommended for patients with <inline-formula><alternatives><inline-graphic xlink:href="ark:/27927/pgjcwgwrgk" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /><mml:math altimg="si4.gif" overflow="scroll" id="d13e1542" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mo>⩾</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>5 metastatic nodes.</p> </sec> </abstract> … (more)
- Is Part Of:
- Oral oncology. Volume 51:Issue 5(2015:May)
- Journal:
- Oral oncology
- Issue:
- Volume 51:Issue 5(2015:May)
- Issue Display:
- Volume 51, Issue 5 (2015)
- Year:
- 2015
- Volume:
- 51
- Issue:
- 5
- Issue Sort Value:
- 2015-0051-0005-0000
- Page Start:
- 514
- Page End:
- 520
- Publication Date:
- 2015-05
- Subjects:
- Mouth -- Cancer -- Periodicals
Mouth -- Tumors -- Periodicals
Mouth Diseases -- Periodicals
Mouth Neoplasms -- Periodicals
Bouche -- Cancer -- Périodiques
Bouche -- Tumeurs -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9943105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/13688375 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/13688375 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.oraloncology.2015.02.098 ↗
- Languages:
- English
- ISSNs:
- 1368-8375
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6277.592000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3269.xml